Cell Bio Human Tech Co.,Ltd (KOSDAQ:318160)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,370.00
+460.00 (7.78%)
At close: Aug 24, 2026

KOSDAQ:318160 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
18,70315,9173,0994,0524,49513,929
Short-Term Investments
33368411,2079,4332,4007,463
Cash & Short-Term Investments
19,03616,60114,30613,4856,89521,392
Cash Growth
60.48%16.04%6.09%95.59%-67.77%69.12%
Accounts Receivable
9,92410,8564,0144,2413,0723,584
Other Receivables
527.7763.834.9696.4932.52154.82
Receivables
10,46210,9204,0494,3373,1043,739
Inventory
15,09213,8584,5508,2819,1066,254
Prepaid Expenses
213.26756.24459.29308.51281.8555.4
Other Current Assets
1,1261,885628.87506.67548.41630.85
Total Current Assets
45,92944,02123,99226,91819,93632,071
Property, Plant & Equipment
36,52335,49324,56822,76423,15223,904
Long-Term Investments
3,4174,6311,034644.17548.66509.54
Other Intangible Assets
1,6771,4471,2551,282818.32817.77
Long-Term Accounts Receivable
-0----
Long-Term Deferred Tax Assets
-503.92457.97557.14825.57248.83
Other Long-Term Assets
2,8662,3621,5971,030701.66517.12
Total Assets
90,41188,45852,90553,19645,98258,069

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
2,6862,984837.061,048861.031,953
Accrued Expenses
1,4951,782600.95564.82709.24414.39
Short-Term Debt
11,04810,5063,6755,8754,9424,735
Current Portion of Long-Term Debt
575.42604.58----
Current Portion of Leases
199.8209.51217.9529.73220.38233.33
Current Income Taxes Payable
347.32241.2462.79540.81573.61,449
Other Current Liabilities
2,5302,870490499.72441.35833.07
Total Current Liabilities
18,88219,1976,2848,5597,7489,617
Long-Term Debt
8,9558,907---9,421
Long-Term Leases
274.17282.77174.5621.8968.78274.54
Pension & Post-Retirement Benefits
465.37451----
Long-Term Deferred Tax Liabilities
550.37550.37----
Other Long-Term Liabilities
70.0965.8134.8453.0760.3429.76
Total Liabilities
29,19729,4556,4938,6347,87719,342

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,6714,6714,6304,6304,1004,100
Additional Paid-In Capital
27,59227,59223,83523,83518,07718,077
Retained Earnings
28,62326,71617,99513,61621,08631,294
Treasury Stock
-4,074-4,074-2,833-37.25-7,916-7,916
Comprehensive Income & Other
1,7781,3912,3382,072-3,648-17,136
Total Common Equity
58,58956,29645,96544,11631,70028,420
Minority Interest
2,1782,261----
Shareholders' Equity
61,21459,00346,41244,56338,10538,726
Total Liabilities & Equity
90,41188,45852,90553,19645,98258,069

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
21,05220,5104,0685,9275,23214,663
Net Cash (Debt)
-2,017-3,90910,2387,5581,6636,728
Net Cash Growth
--35.46%354.48%-75.28%-43.71%
Net Cash Per Share
-241.24-476.291147.60894.55237.54852.31
Filing Date Shares Outstanding
8.388.388.549.2677
Total Common Shares Outstanding
8.388.388.549.2677
Working Capital
27,04724,82317,70918,35912,18722,454
Book Value Per Share
6995.086721.255383.594765.584527.974059.42
Tangible Book Value
56,91254,84944,71042,83430,88227,602
Tangible Book Value Per Share
6794.906548.535236.554627.084411.093942.62
Land
-6,7572,3602,3602,3602,360
Buildings
-11,5958,9868,4428,4598,282
Machinery
-15,82311,56510,28710,74210,622
Construction In Progress
-234.69766.68128.0730.27310.99